Skip to content

Evaluation of Topical and Intravenous Tranexamic Acid in Surgical Treatment of Lumbar Degenerative Disease

Topical and Intravenous Use of Tranexamic Acid in Posterior Lumbar Interbody Fusion - A Prospective, Double-blind, Randomized Study

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02496364
Enrollment
0
Registered
2015-07-14
Start date
2014-03-01
Completion date
2015-02-01
Last updated
2021-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Disc Degeneration, Surgical Procedure, Unspecified

Brief summary

Evaluation of Topical and Intravenous Tranexamic Acid in Surgical Treatment of Lumbar Degenerative Disease

Interventions

OTHERObservational

Sponsors

Vinicius Magno da Rocha, MD, MSc
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Healthy volunteers
No

Design outcomes

Primary

MeasureTime frame
Observation1

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026